BioAsia 2024 to focus on data and AI for life sciences
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Subscribe To Our Newsletter & Stay Updated